These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30562268)

  • 1. The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids.
    Bruehl S; Burns JW; Morgan A; Koltyn K; Gupta R; Buvanendran A; Edwards D; Chont M; Kingsley PJ; Marnett L; Stone A; Patel S
    Pain; 2019 Mar; 160(3):676-687. PubMed ID: 30562268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.
    Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Kinner E; Schuster E; Passik S; France CR
    Pain; 2013 Sep; 154(9):1856-1864. PubMed ID: 23748117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial factors predict opioid analgesia through endogenous opioid function.
    Burns JW; Bruehl S; France CR; Schuster E; Orlowska D; Buvanendran A; Chont M; Gupta RK
    Pain; 2017 Mar; 158(3):391-399. PubMed ID: 27898491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Resting Plasma β-Endorphin Levels Predict Responses to Opioid Analgesics?
    Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Orlowska D; Schuster E; France CR
    Clin J Pain; 2017 Jan; 33(1):12-20. PubMed ID: 27183154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does aerobic exercise training alter responses to opioid analgesics in individuals with chronic low back pain? A randomized controlled trial.
    Bruehl S; Burns JW; Koltyn K; Gupta R; Buvanendran A; Edwards D; Chont M; Wu YH; Stone A
    Pain; 2021 Aug; 162(8):2204-2213. PubMed ID: 33394881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration.
    Bruehl S; Burns JW; Gupta R; Buvanendran A; Chont M; Schuster E; France CR
    Reg Anesth Pain Med; 2014; 39(2):120-5. PubMed ID: 24553304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness.
    Burns JW; Bruehl S; France CR; Schuster E; Orlowska D; Chont M; Gupta RK; Buvanendran A
    J Pain; 2017 Aug; 18(8):923-932. PubMed ID: 28365372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients.
    Bruehl S; Burns JW; Passik SD; Gupta R; Buvanendran A; Chont M; Schuster E; Orlowska D; France CR
    J Pain; 2015 Jul; 16(7):666-75. PubMed ID: 25892658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are endogenous opioid mechanisms involved in the effects of aerobic exercise training on chronic low back pain? A randomized controlled trial.
    Bruehl S; Burns JW; Koltyn K; Gupta R; Buvanendran A; Edwards D; Chont M; Wu YH; Qu'd D; Stone A
    Pain; 2020 Dec; 161(12):2887-2897. PubMed ID: 32569082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported cumulative medical opioid exposure and subjective responses on first use of opioids predict analgesic and subjective responses to placebo-controlled opioid administration.
    Bruehl S; Stone AL; Palmer C; Edwards DA; Buvanendran A; Gupta R; Chont M; Kennedy M; Burns JW
    Reg Anesth Pain Med; 2019 Jan; 44(1):92-99. PubMed ID: 30640659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater Conditioned Pain Modulation Is Associated With Enhanced Morphine Analgesia in Healthy Individuals and Patients With Chronic Low Back Pain.
    Bruehl S; France CR; Stone AL; Gupta R; Buvanendran A; Chont M; Burns JW
    Clin J Pain; 2021 Jan; 37(1):20-27. PubMed ID: 33086239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal morphine administration reduces postoperative pain and peripheral endocannabinoid levels in total knee arthroplasty patients: a randomized clinical trial.
    Kaczocha M; Azim S; Nicholson J; Rebecchi MJ; Lu Y; Feng T; Romeiser JL; Reinsel R; Rizwan S; Shodhan S; Volkow ND; Benveniste H
    BMC Anesthesiol; 2018 Feb; 18(1):27. PubMed ID: 29486720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between endogenous opioid function and opioid analgesic adverse effects.
    Gupta RK; Bruehl S; Burns JW; Buvanendran A; Chont M; Schuster E; France CR
    Reg Anesth Pain Med; 2014; 39(3):219-24. PubMed ID: 24682081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low-dose Naloxone as an Adjuvant to Patient Controlled Analgesia (PCA) With Morphine for Postoperative Pain Relief Following Lumber Discectomy: A Double-blind, Randomized, Placebo-controlled Trial.
    Firouzian A; Gholipour Baradari A; Alipour A; Emami Zeydi A; Zamani Kiasari A; Emadi SA; Kheradmand B; Hadadi K
    J Neurosurg Anesthesiol; 2018 Jan; 30(1):26-31. PubMed ID: 27673505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?
    Bruehl S; Burns JW; Chung OY; Chont M
    Eur J Pain; 2012 Mar; 16(3):370-80. PubMed ID: 22337161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opioids and chronic pain intensity: interactions with level of disability.
    Bruehl S; Chung OY; Ward P; Johnson B
    Clin J Pain; 2004; 20(5):283-92. PubMed ID: 15322434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain.
    Chu LF; D'Arcy N; Brady C; Zamora AK; Young CA; Kim JE; Clemenson AM; Angst MS; Clark DJ
    Pain; 2012 Aug; 153(8):1583-1592. PubMed ID: 22704854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between negative affect and opioid analgesia in patients with discogenic low back pain.
    Wasan AD; Davar G; Jamison R
    Pain; 2005 Oct; 117(3):450-461. PubMed ID: 16154274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study.
    Gimbel J; Spierings ELH; Katz N; Xiang Q; Tzanis E; Finn A
    Pain; 2016 Nov; 157(11):2517-2526. PubMed ID: 27434505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.